Double Dhamaka! 1:1 Bonus Share & 5:1 Stock Split Announced: High ROE & High ROCE Multibagger Stock To Keep Under Radar

Kiran Shroff
Double Dhamaka! 1:1 Bonus Share & 5:1 Stock Split Announced: High ROE & High ROCE Multibagger Stock To Keep Under Radar

The shares of the company have an ROE of 35 per cent and an ROCE of 37 per cent.

Enser Communications Ltd has announced a significant corporate action involving the issuance of bonus equity shares, stock split of existing shares, and an increase in authorized share capital. The company plans to issue one new fully paid-up equity share of Rs. 10 each for every existing share held by eligible shareholders on the record date, subject to shareholder approval. Additionally, the company intends to sub-divide each existing Rs 10 per share into five Rs 2 per share, with the record date for this sub-division to be announced later. To accommodate these changes, the company will increase its authorized share capital from Rs 11 crore to Rs 20 crore, requiring an amendment to its Memorandum of Association. The bonus shares are expected to be credited or dispatched within two months of board approval.

Enser Communications Ltd., established in 2008, is a prominent player in the communications sector, offering a comprehensive suite of Business Process Management (BPM) services. The company caters to diverse industries, including insurance, e-commerce, education, and travel. Its core business verticals encompass customer acquisition, customer service, IT infrastructure management, and data management. Enser provides a wide range of services, such as business analytics, CRM, IVRS, customer interaction management, technology-enabled infrastructure development, payment solutions, process re-engineering, ERP implementation, application development, web chat, transaction processing, debt collection, sales, customer support, BPO/BPM, knowledge process consulting, contact center, and customer acquisition.

DSIJ’s 'multibagger Pick’ service recommends well researched multibagger stocks with High Returns potential. If this interests you, do download the service details here.

Additionally, the company engages in trading communication equipment, facilitating networking, and offering website development, systems analysis, and management information systems. Enser serves a diverse clientele, including major players like Acko General Insurance, Ola Financial Services, Metis Eduventures and National Health Authority. The company has a market cap of Rs 261 crore.

According to half-yearly results, the net sales increased by 116 per cent to Rs 39.02 crore and net profit increased by 127 per cent to Rs 4.85 crore in H1FY25 comparted to H1FY24. In its annual results, the net sales increased by 81 per cent to Rs 46.08 crore and net profit increased by 290 per cent to Rs 5.27 crore in FY24 comparted to FY23. The shares of the company have an ROE of 35 per cent and an ROCE of 37 per cent. The stock gave multibagger returns of 380 per cent from its 52-week low of Rs 62.25 per share. Investors should keep an eye on this micro-cap stock.

Disclaimer: The article is for informational purposes only and not investment advice. 

Rate this article:
3.8

DSIJ MINDSHARE

Mkt Commentary20-Dec, 2024

Swing Trading22-Dec, 2024

IPO Analysis20-Dec, 2024

Mindshare20-Dec, 2024

IPO Analysis20-Dec, 2024

Knowledge

MF15-Nov, 2024

General15-Nov, 2024

MF14-Nov, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR